• AstraZeneca Finance LLC launched a EUR 2.55 billion bond offering, with four debt securities admitted to trading on the LSE’s Main Market.
• Admission to trading was effective Sept. 1, 2026.
• The offering comprised Notes due 2030, 2032, 2035, and 2038, with aggregate nominal amounts ranging from EUR 500 million to EUR 750 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AstraZeneca plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001654954-26-007992), on September 01, 2026, and is solely responsible for the information contained therein.